TD Asset Management
MIRM icon

TD Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

TD Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.67M Buy
39,888
+6,200
+18% +$622K ﹤0.01% 817
2026
Q1 		$3.11M Buy
33,688
+10,412
+45% +$979K ﹤0.01% 877
2025
Q4 		$1.84M Buy
23,276
+7,876
+51% +$565K ﹤0.01% 1005
2025
Q3 		$1.13M Buy
+15,400
New +$979K ﹤0.01% 1069
2024
Q2 		– Sell
-59,800
Closed -$1.5M – 1400
2024
Q1 		$1.5M Buy
59,800
+12,800
+27% +$352K ﹤0.01% 1094
2023
Q4 		$1.39M Buy
+47,000
New +$1.42M ﹤0.01% 1108

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Asset Management's MIRM Position: Q2 2026 in Review

TD Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 18% in Q2 2026, buying an estimated $622K and bringing the position to 39,888 shares worth $4.67M. The position accounts for ﹤0.01% of the portfolio, ranked #817.

TD Asset Management first reported a position in MIRM in Q4 2023 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • TD Asset Management held 39,888 shares of Mirum Pharmaceuticals worth $4.67M as of Q2 2026.
  • TD Asset Management bought 6,200 Mirum Pharmaceuticals shares in Q2 2026, an estimated $622K.
  • Mirum Pharmaceuticals made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #817 holding.
  • TD Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.